BSX vs. RY.TO
BSX (Boston Scientific Corporation) and RY.TO (Royal Bank of Canada) are both stocks. BSX operates in Medical Devices (Healthcare), while RY.TO operates in Banks - Diversified (Financial Services). Over the past 10 years, BSX returned 7.42%/yr vs 17.10%/yr for RY.TO. At a 0.30 correlation, their price movements are largely independent.
Performance
BSX vs. RY.TO - Performance Comparison
Loading charts...
Different Trading Currencies
BSX is traded in USD, while RY.TO is traded in CAD. To make them comparable, the RY.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, BSX achieves a -50.80% return, which is significantly lower than RY.TO's 18.35% return. Over the past 10 years, BSX has underperformed RY.TO with an annualized return of 7.42%, while RY.TO has yielded a comparatively higher 17.10% annualized return.
BSX
- 1D
- -0.55%
- 1M
- -11.59%
- YTD
- -50.80%
- 6M
- -49.33%
- 1Y
- -52.40%
- 3Y*
- -2.85%
- 5Y*
- 1.80%
- 10Y*
- 7.42%
RY.TO
- 1D
- 0.07%
- 1M
- 10.66%
- YTD
- 18.35%
- 6M
- 22.02%
- 1Y
- 60.20%
- 3Y*
- 33.49%
- 5Y*
- 18.07%
- 10Y*
- 17.10%
BSX vs. RY.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | -50.80% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
RY.TO Royal Bank of Canada | 18.35% | 46.28% | 23.88% | 12.48% | -7.39% | 33.15% | 9.11% | 19.24% | -12.83% | 25.63% |
Correlation
The correlation between BSX and RY.TO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jul 12, 2006 | 0.30 |
Over the past year, the correlation between BSX and RY.TO has dropped to 0.06 - well below their long-term average of 0.30, suggesting their price drivers have been diverging.
Fundamentals
BSX:
$70.13B
RY.TO:
CA$389.54B
BSX:
$2.38
RY.TO:
CA$15.77
BSX:
19.74
RY.TO:
17.69
BSX:
0.44
RY.TO:
2.60
BSX:
3.40
RY.TO:
3.25
BSX:
2.71
RY.TO:
3.01
BSX:
$20.62B
RY.TO:
CA$120.33B
BSX:
$14.52B
RY.TO:
CA$65.64B
BSX:
$4.76B
RY.TO:
CA$14.74B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BSX vs. RY.TO — Risk / Return Rank
BSX
RY.TO
BSX vs. RY.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and Royal Bank of Canada (RY.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BSX | RY.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.66 | ||
| Sortino ratioReturn per unit of downside risk | -8.29 | ||
| Omega ratioGain probability vs. loss probability | 0.67 | 1.73 | -1.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | 6.16 | -7.09 |
| Martin ratioReturn relative to average drawdown | -2.00 | 22.75 | -24.75 |
Loading charts...
Drawdowns
BSX vs. RY.TO - Drawdown Comparison
The maximum BSX drawdown since its inception was -89.15%, which is greater than RY.TO's maximum drawdown of -63.01%. Use the drawdown chart below to compare losses from any high point for BSX and RY.TO.
Loading charts...
Drawdown Indicators
| BSX | RY.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.15% | -63.01% | -26.14% |
Max Drawdown (1Y)Largest decline over 1 year | -56.62% | -9.82% | -46.80% |
Max Drawdown (3Y)Largest decline over 3 years | -56.62% | -19.58% | -37.04% |
Max Drawdown (5Y)Largest decline over 5 years | -56.62% | -28.47% | -28.15% |
Max Drawdown (10Y)Largest decline over 10 years | -56.62% | -39.33% | -17.29% |
Current DrawdownCurrent decline from peak | -56.62% | 0.00% | -56.62% |
Average DrawdownAverage peak-to-trough decline | -38.76% | -9.84% | -28.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.23% | 2.65% | +23.58% |
Volatility
BSX vs. RY.TO - Volatility Comparison
Boston Scientific Corporation (BSX) has a higher volatility of 15.84% compared to Royal Bank of Canada (RY.TO) at 4.33%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than RY.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BSX | RY.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.84% | 4.33% | +11.51% |
Volatility (6M)Calculated over the trailing 6-month period | 32.83% | 10.83% | +22.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.77% | 14.58% | +20.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.69% | 16.55% | +9.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.29% | 18.66% | +8.63% |
Dividends
BSX vs. RY.TO - Dividend Comparison
BSX has not paid dividends to shareholders, while RY.TO's dividend yield for the trailing twelve months is around 2.28%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RY.TO Royal Bank of Canada | 2.28% | 2.58% | 3.23% | 3.99% | 3.90% | 3.22% | 4.10% | 3.96% | 4.03% | 3.39% | 3.57% | 4.15% |
Financials
BSX vs. RY.TO - Financials Comparison
This section allows you to compare key financial metrics between Boston Scientific Corporation and Royal Bank of Canada. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BSX vs. RY.TO - Profitability Comparison
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
RY.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Royal Bank of Canada reported a gross profit of 16.52B and revenue of 33.95B. Therefore, the gross margin over that period was 48.7%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
RY.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Royal Bank of Canada reported an operating income of 7.10B and revenue of 33.95B, resulting in an operating margin of 20.9%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
RY.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Royal Bank of Canada reported a net income of 5.51B and revenue of 33.95B, resulting in a net margin of 16.2%.
Frequently Asked Questions
BSX and RY.TO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for BSX and RY.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer